Myocardial BDNF regulates cardiac bioenergetics through the transcription factor Yin Yang 1
暂无分享,去创建一个
D. Kass | B. O’Rourke | An-Chi Wei | I. Scott | N. Paolocci | S. Shiva | Xue Yang | Hong Jiang | D. Bedja | Guangshuo Zhu | N. Feng | Ray Zimmerman | Manling Zhang | Qin Wang
[1] H. Völzke,et al. Brain-derived neurotrophic factor is related with adverse cardiac remodeling and high NTproBNP , 2019, Scientific Reports.
[2] Matthew C. Hill,et al. Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development , 2019, Nature Communications.
[3] E. Castrén,et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors , 2019, Cell.
[4] P. Bekinschtein,et al. Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain , 2019, Front. Cell. Neurosci..
[5] I. Scott,et al. Loss of GCN5L1 in cardiac cells limits mitochondrial respiratory capacity under hyperglycemic conditions , 2019, Physiological Reports.
[6] U. Ekelund,et al. Sitting Time, Physical Activity, and Risk of Mortality in Adults. , 2019, Journal of the American College of Cardiology.
[7] A. Drilon,et al. NTRK fusion-positive cancers and TRK inhibitor therapy , 2018, Nature Reviews Clinical Oncology.
[8] Steven E. Nissen,et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing , 2018, JAMA network open.
[9] S. Yusuf,et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study , 2017, The Lancet.
[10] Daniel S. Day,et al. YY1 Is a Structural Regulator of Enhancer-Promoter Loops , 2017, Cell.
[11] I. Atanassov,et al. Increased Total mtDNA Copy Number Cures Male Infertility Despite Unaltered mtDNA Mutation Load. , 2017, Cell Metabolism.
[12] Rick B. Vega,et al. Molecular Mechanisms Underlying Cardiac Adaptation to Exercise. , 2017, Cell metabolism.
[13] J. Granger,et al. Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart. , 2016, Journal of Visualized Experiments.
[14] L. Wilkins. Circulating Brain‐Derived Neurotrophic Factor Concentrations and the Risk of Cardiovascular Disease in the Community , 2016, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.
[15] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[16] O. Kretz,et al. Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure , 2015, Circulation research.
[17] L. Cantley,et al. Regulation of mTORC1 by PI3K signaling. , 2015, Trends in cell biology.
[18] Y. Izumiya,et al. Significance of low plasma levels of brain-derived neurotrophic factor in patients with heart failure. , 2015, The American journal of cardiology.
[19] Rick B. Vega,et al. Maintaining ancient organelles: mitochondrial biogenesis and maturation. , 2015, Circulation research.
[20] D. Kass,et al. Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation , 2015, Autonomic Neuroscience.
[21] K. Oba,et al. Serum Brain-Derived Neurotrophic Factor Level Predicts Adverse 1 Clinical Outcomes in Patients with Heart Failure , 2017 .
[22] R. Hughes,et al. TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination , 2014, Molecular and Cellular Neuroscience.
[23] S. Anker,et al. Metabolic impairment in heart failure: the myocardial and systemic perspective. , 2014, Journal of the American College of Cardiology.
[24] M. White,et al. Insulin Receptor Substrates Are Essential for the Bioenergetic and Hypertrophic Response of the Heart to Exercise Training , 2014, Molecular and Cellular Biology.
[25] M. Mattson,et al. BDNF mediates adaptive brain and body responses to energetic challenges , 2014, Trends in Endocrinology & Metabolism.
[26] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[27] Markus Krane,et al. Essential and Unexpected Role of Yin Yang 1 to Promote Mesodermal Cardiac Differentiation , 2013, Circulation research.
[28] D. Ginty,et al. Sexually Dimorphic BDNF Signaling Directs Sensory Innervation of the Mammary Gland , 2012, Science.
[29] M. Mattson,et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines , 2012, Nature Communications.
[30] S. Cortassa,et al. GSH or Palmitate Preserves Mitochondrial Energetic/Redox Balance, Preventing Mechanical Dysfunction in Metabolically Challenged Myocytes/Hearts From Type 2 Diabetic Mice , 2012, Diabetes.
[31] K. Chowdhury,et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy , 2012, Nature Communications.
[32] I. Komuro,et al. Brain-Derived Neurotrophic Factor Protects Against Cardiac Dysfunction After Myocardial Infarction via a Central Nervous System–Mediated Pathway , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[33] D. Kass,et al. Pathological Cardiac Hypertrophy Alters Intracellular Targeting of Phosphodiesterase Type 5 From Nitric Oxide Synthase-3 to Natriuretic Peptide Signaling , 2012, Circulation.
[34] D. Kelly,et al. The PGC-1 cascade as a therapeutic target for heart failure. , 2011, Journal of molecular and cellular cardiology.
[35] Iain McDonald,et al. Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart Mitochondria* , 2011, The Journal of Biological Chemistry.
[36] Dong I. Lee,et al. Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5. , 2010, Journal of the American College of Cardiology.
[37] M. Bilgen,et al. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. , 2010, The Journal of clinical investigation.
[38] Yang Liu,et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone , 2010, Proceedings of the National Academy of Sciences.
[39] M. Febbraio,et al. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase , 2009, Diabetologia.
[40] W. Kraus,et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.
[41] T. McKinsey,et al. YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5. , 2008, Molecular Biology of the Cell.
[42] R. Roberts. Faculty Opinions recommendation of mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. , 2007 .
[43] Gail Mandel,et al. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA , 2007, Nature Neuroscience.
[44] M. Birnbaum,et al. A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. , 2007, Cell metabolism.
[45] B. Bonavida,et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.
[46] G. Dorn,et al. Protein kinase cascades in the regulation of cardiac hypertrophy. , 2005, The Journal of clinical investigation.
[47] J. Huss,et al. Nuclear receptor signaling and cardiac energetics. , 2004, Circulation research.
[48] M. Piepoli,et al. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.
[49] Daisuke Hattori,et al. DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.
[50] Chun Li Zhang,et al. Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.
[51] Xianlin Han,et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.
[52] S. Rafii,et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. , 2000, Development.
[53] R. Belardinelli,et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. , 1999, Circulation.
[54] E. Jennings,et al. DNA binding sites for the transcriptional activator/repressor YY1. , 1995, Nucleic acids research.
[55] Y. Barde,et al. Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain. , 1990, The EMBO journal.